Literature DB >> 8168561

Prevalence of hepatitis C, B and D markers in cancer patients in Turkey.

A Topeli, O Ozyilkan, E Ozyilkan, A Kars, D Firat.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 8168561     DOI： 10.1007/bf02026124

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN： 0934-9723            Impact factor:   3.267


× No keyword cloud information.
  6 in total

1.  Prevalence of hepatitis A, B and C in Turkey.

Authors:  L Doganci; T Haznedaroglu
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-07       Impact factor: 3.267

2.  Epidemiology of hepatitis C virus. A preliminary study in volunteer blood donors.

Authors:  C E Stevens; P E Taylor; J Pindyck; Q L Choo; D W Bradley; G Kuo; M Houghton
Journal:  JAMA       Date:  1990-01-05       Impact factor: 56.272

3.  Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome.

Authors:  Q L Choo; G Kuo; A J Weiner; L R Overby; D W Bradley; M Houghton
Journal:  Science       Date:  1989-04-21       Impact factor: 47.728

4.  Discrepant results of different tests for antibodies to hepatitis C in children with malignant diseases and in patients on renal replacement therapy.

Authors:  P Rautenberg; R Schneppenheim; G Leimenstoll; H Behnke; G Loose
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-11       Impact factor: 3.267

5.  Hepatitis C-related hepatocellular carcinoma. Prevalence and significance.

Authors:  R H Resnick; R Koff
Journal:  Arch Intern Med       Date:  1993-07-26

6.  Prevalence of markers of hepatitis B virus infection in various countries: a WHO collaborative study.

Authors:  O Sobĕslavský
Journal:  Bull World Health Organ       Date:  1980       Impact factor: 9.408
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.